Experience: Trustlink (Pty) Ltd · Education: University of Pretoria/Universiteit van Pretoria · Location: City of Johannesburg · 150 connections on LinkedIn. View Jaco Greyling’s profile on LinkedIn, a professional community of 1 billion members.
Jaco has more than 15 years experience as Zutari / Aurecon Team Leader in design and… · Experience: Zutari · Education: Msc Eng (Structures) – University of Stellenbosch · Location: South Africa · 500+ connections on LinkedIn. View Jaco De Villiers’ profile on LinkedIn, a professional community of 1 billion members.
I’m a former management consultant who transitioned into industry leadership, currently… · Experience: Foxtel · Education: SAICA · Location: South Turramurra · 500+ connections on LinkedIn. View Jaco Fouche’s profile on LinkedIn, a professional community of 1 billion members.
Experience: Homebase · Location: London. View Jaco Terri’s profile on LinkedIn, a professional community of 1 billion members.
View the profiles of professionals named “Jaco Smit” on LinkedIn. There are 100+ professionals named “Jaco Smit”, who use LinkedIn to exchange information, ideas, and …
Circulation Marketing Manager at The Citizen Newspaper · 🔹 Dedicated and results-driven professional with a strong track record in the print media industry, supported by experience in the e-commerce space. I bring a dynamic mix of strategic marketing insight and hands-on expertise in commercial management, circulation (sales) management, retail marketing, and sales leadership. 🔹 My …
Artificial intelligence can transform healthcare systems by streamlining service delivery and strengthening disease monitoring in underserved regions.
Artificial intelligence has entered dentistry with remarkable speed. Machine learning systems now assist clinicians in detecting caries, interpreting radiographs, identifying periodontal changes, and screening oral lesions with levels of consistency approaching expert performance. Ethical discussion surrounding dental AI has largely focused on improving prediction accuracy. Clinical medicine recognizes uncertainty as an essential component of responsible diagnosis. This paper argues that responsible AI-assisted dentistry requires recognition of a critical ethical boundary — the moment at which automated diagnostic expression should be intentionally withheld.
Algorithmic silence may be defined as the intentional withholding of automated diagnostic recommendation when model confidence, contextual validity, or ethical safety thresholds are not sufficiently satisfied. Silence functions as a designed safeguard embedded within clinical decision-support architecture, allowing uncertainty to become an actionable clinical signal.
Oral disease diagnosis represents one of the most uncertainty-rich domains of healthcare. AI systems trained on image datasets may perform effectively in advanced disease detection while remaining vulnerable in early or atypical presentations. Calibrated abstention signals prompting referral or further investigation may better protect patients than forced classification.
Continuous algorithmic prediction introduces the risk of responsibility diffusion. Healthcare ethics maintains that the individual who decides bears responsibility. Algorithmic silence helps re-establish accountability by explicitly returning decision authority to the practitioner whenever uncertainty exceeds safe limits.
Operationalizing algorithmic silence requires intentional design strategies including uncertainty quantification models, calibrated confidence thresholds, out-of-distribution detection, abstention-enabled neural networks, and clinician override prioritization.
Algorithmic silence represents an essential evolution in AI-assisted oral healthcare. By embedding uncertainty awareness within clinical systems, dentistry can preserve professional judgment while benefiting from computational intelligence.
About the author
Dr. Ameed Khalid Abdul-Hamid is an Iraqi–British dental surgeon and academic researcher, internationally recognized for his contributions to artificial intelligence in dentistry and healthcare. He serves as Chairman of the Arab Organisation for Artificial Intelligence in Healthcare and Chairman of the Saudi-British Medical Forum (London). His research focuses on AI-enabled diagnostics, digital health systems, and the ethical, responsible integration of artificial intelligence in clinical care.
Defensive medicine used to mean ordering one more test, writing one more line in the note, or documenting that risks were discussed “in detail.” That definition no longer holds. In the AI era, defensive medicine is less about doing more, and more about how decisions were made, who contributed to them, and how uncertainty was handled once artificial intelligence entered the workflow.
The medical record is no longer written by a single clinician at the end of a long shift. It is increasingly co-authored by ambient scribes, summarization engines, clinical decision support tools, and large language models that can sound confident even when they are wrong.
Here is the legal reality clinicians need to absorb early: When AI enters the chart, responsibility does not shift. It concentrates.
Most clinicians already use AI, whether they call it that or not. Ambient documentation, auto-generated assessments, triage tools, record summarization, and literature synthesis are now routine. These tools reduce friction and save time. But they also introduce a new medico-legal problem:
If an AI-generated statement is wrong and it appears in the chart, who owns it?
The law has been consistent so far. The signer owns the note. Courts do not meaningfully distinguish between human-authored and AI-assisted documentation. The medical record remains a clinician’s representation of reality, regardless of how the text was produced. That alone should change how we document.
One of the most dangerous myths in healthcare AI is the belief that hallucinations are technical glitches that will be fixed with better models. They will not. Hallucinations are a structural feature of large language models. These systems do not retrieve truth. They generate statistically plausible language based on patterns in prior data.
This behaviour is not accidental. Models are rewarded for producing answers, not for saying “I don’t know.” In fact, any AI model that claims over 75 percent accuracy in a complex system shouldn’t be trusted. It’s probably learning the wrong thing very well.
Language models amplify this risk. They sound authoritative. They write cleanly. They can fabricate references, guidelines, or reasoning unless the reader already knows the answer. In healthcare, fluency without grounding is not neutral. It is dangerous.
We are repeatedly told to trust AI because it is “95 percent accurate.” However:
In medicine, what matters is not how often a model is right in aggregate, but how it fails, when it fails, and whether humans can detect that failure in time. Clean metrics do not equal resilient performance.
When AI contributes to clinical reasoning or documentation, attribution becomes a safety tool. Attribution documents judgment. It shows that AI assisted but did not replace reasoning. Years later, that distinction can be very important.
Clinicians may be exposed when they use AI and override it, especially after adverse outcomes. This tension has been described as the negative outcome penalty paradox: clinicians can be punished whether they follow or reject AI recommendations once AI becomes normalized. Defensive medicine now requires reasoned positioning, not blind adoption or avoidance.
Traditional defensive documentation emphasized thoroughness; AI-era defensive documentation emphasizes provenance. Practical shifts clinicians should adopt now:
Clinicians do not need to become data scientists, but they do need to understand where hallucinations are most likely, how training data limitations affect output, and why confidence does not equal correctness. Ignorance will not be a defense when AI tools are widely available and increasingly normalized.
Augmented intelligence keeps the clinician explicitly in the loop. It reinforces that AI assists but does not decide. The moment AI silently replaces reasoning in documentation, both patient safety and legal defensibility erode. The chart reclaims its original role: a legal narrative of clinical reasoning under uncertainty.
About the author
Dr. Hassan Bencheqroun is a pulmonary and critical care physician, assistant professor at the University of California Riverside School of Medicine, and CEO of Medical AI Academy. He hosts “The AI-Ready Doctor podcast” and is an active AiMed participant and speaker bridging clinical care, education, and technology.
Fig. 1: Agentic AI orchestration across clinical, administrative, regulatory, and patient engagement domains.
The healthcare industry has entered a transformative era. Agentic artificial intelligence — systems capable of autonomous reasoning, planning, and multi-step task execution with defined human oversight — is transitioning from research concept to enterprise deployment.
Unlike traditional machine learning that excels at narrow pattern recognition or generative AI that produces content reactively, agentic AI operates with goal-directed autonomy: decomposing complex objectives, coordinating specialized agents across disparate systems, and adapting strategies based on outcomes. This paradigm shift addresses healthcare’s most persistent challenges, including administrative burden consuming 20 percent of institutional budgets, physician burnout, and the growing complexity of clinical decision-making.1
The acceleration in late 2025 has been remarkable. On December 1, 2025, the U.S. Food and Drug Administration announced agentic AI deployment for all agency employees — the first major regulatory body to institutionalize autonomous AI workflows for administrative functions including meeting management, document processing, and compliance operations.2 Critically, these internal tools support agency operations but do not autonomously render pre-market review decisions. Days later, the Department of Health and Human Services released its comprehensive AI strategy positioning autonomous systems as central to federal health operations.3
The distinction between agentic AI and its predecessors is substantive. Traditional machine learning excels at classification within narrow domains. Generative AI expanded to content creation. Agentic AI introduces systems that pursue defined goals with limited supervision, typically employing multiple specialized agents coordinated through an orchestration layer.4
Technical precision requires distinguishing workflow automation from true goal-directed autonomy. Research published in Frontiers in Artificial Intelligence found that agentic architectures can reduce cognitive workload by up to 52 percent compared to traditional clinical decision support.1
The market is consolidating around major platforms. Microsoft’s healthcare agent orchestrator provides pre-configured agents for clinical trial matching and tumor board preparation. Epic Systems has deployed multiple AI agents: Emmie (patient engagement), Art (provider communications), and Penny (revenue cycle management).6
Table 1: Healthcare Agentic AI Platform Comparison (January 2026)
| Platform | Capabilities | Deployment Considerations |
|---|---|---|
| Microsoft Healthcare Agent Orchestrator | Multi-agent orchestration, clinical trial matching | Azure AI Foundry; broader EHR interoperability |
| Epic (Emmie, Art, Penny, Cosmos) | Patient engagement, provider communications, revenue cycle | Version-dependent; 6-12-month configuration |
| Nuance Dragon Copilot | Ambient clinical and nursing documentation | Generally available; multi-EHR integration |
| Atropos Evidence Agent | Proactive real-world evidence at point of care | Pilot deployments; addresses evidence accessibility |
The FDA’s database lists over 1,250 AI-enabled medical devices authorized for marketing, but the vast majority are narrow diagnostic imaging tools. True agentic systems for clinical decision-making face the most stringent Class III regulatory pathway.9
The liability landscape presents novel challenges. Traditionally, the “learned intermediary” doctrine shields device manufacturers when physicians exercise independent judgment. However, agentic systems that execute autonomously may eliminate this shield, exposing manufacturers to direct liability.12
Table 2: Implementation Prioritization Framework
| Phase | Use Cases | Risk Profile | Timeline |
|---|---|---|---|
| Immediate (2026) | Scheduling, prior auth, messaging triage | Low clinical risk | 3-6 months |
| Near-term (2026-2027) | Ambient documentation, coding assistance | Moderate risk | 6-12 months |
| Medium-term (2027-2028) | Clinical decision support, care coordination | Higher risk | 12-24 months |
| Longer-term (2028+) | Autonomous monitoring, closed-loop systems | Highest risk | 24+ months |
About the Author
Dr. Srikanth Mahankali is a leading expert in the implementation of medical AI and policy. As CEO of Shree Advisory & Consulting and a member of the NSF/MITRE AI Workforce Working Group, he shapes national AI strategy while driving responsible innovation.
